These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 26771907)

  • 1. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray.
    Pan M; Han J; Zhen L; Yang X; Li R; Liao C; Li DZ
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():164-7. PubMed ID: 26771907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal Diagnostic Value of Chromosomal Microarray in Fetuses with Nuchal Translucency Greater than 2.5 mm.
    Zhang Z; Hu T; Wang J; Li Q; Wang H; Liu S
    Biomed Res Int; 2019; 2019():6504159. PubMed ID: 32908864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of the BACs-on-Beads™ assay versus karyotyping for prenatal detection of chromosomal abnormalities: a retrospective consecutive case series.
    Choy KW; Kwok YK; Cheng YK; Wong KM; Wong HK; Leung KO; Suen KW; Adler K; Wang CC; Lau TK; Schermer MJ; Lao TT; Leung TY
    BJOG; 2014 Sep; 121(10):1245-52. PubMed ID: 24893808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal microarray in fetuses with increased nuchal translucency.
    Lund IC; Christensen R; Petersen OB; Vogel I; Vestergaard EM
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):95-100. PubMed ID: 25393210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased nuchal translucency, hydrops fetalis or hygroma colli. A new test strategy for early fetal aneuploidy detection.
    Jenderny J; Schmidt W; Hecher K; Hackelöer BJ; Kerber S; Kochhan L; Held KR
    Fetal Diagn Ther; 2001; 16(4):211-4. PubMed ID: 11399881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of quantitative fluorescence PCR analysis in high-risk pregnancies after combined first-trimester screening.
    Lildballe DL; Vogel I; Petersen OB; Vestergaard EM
    Dan Med J; 2014 Nov; 61(11):A4964. PubMed ID: 25370964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study.
    Chitty LS; Kagan KO; Molina FS; Waters JJ; Nicolaides KH
    BMJ; 2006 Feb; 332(7539):452-5. PubMed ID: 16476673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
    Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH
    Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings.
    Meck JM; Kramer Dugan E; Matyakhina L; Aviram A; Trunca C; Pineda-Alvarez D; Aradhya S; Klein RT; Cherry AM
    Am J Obstet Gynecol; 2015 Aug; 213(2):214.e1-5. PubMed ID: 25843063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined first-trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT.
    Gadsbøll K; Vogel I; Kristensen SE; Pedersen LH; Hyett J; Petersen OB;
    Ultrasound Obstet Gynecol; 2024 Oct; 64(4):470-479. PubMed ID: 38642365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency: a French multicenter study.
    Egloff M; Hervé B; Quibel T; Jaillard S; Le Bouar G; Uguen K; Saliou AH; Valduga M; Perdriolle E; Coutton C; Coston AL; Coussement A; Anselem O; Missirian C; Bretelle F; Prieur F; Fanget C; Muti C; Jacquemot MC; Beneteau C; Le Vaillant C; Vekemans M; Salomon LJ; Vialard F; Malan V
    Ultrasound Obstet Gynecol; 2018 Dec; 52(6):715-721. PubMed ID: 29027723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.
    Leung TY; Vogel I; Lau TK; Chong W; Hyett JA; Petersen OB; Choy KW
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):314-9. PubMed ID: 21400624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Implementation of arrays in first trimester prenatal diagnosis].
    Trková M; Putzová M; Bečvářová V; Horáček J; Soldátová I; Krautová L; Sekowská M; Hodačová J; Hnyková L; Hlavová E; Smetanová D; Stejskal D
    Ceska Gynekol; 2015 Jun; 80(3):176-80. PubMed ID: 26087211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of chromosome microarray analysis for fetuses with increased nuchal translucency and a normal karyotype].
    Yang X; Fu F; Li R; Zhang Y; Wan J; Yang X; Han J; Pan M; Zhen L; Liao C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Jun; 32(3):370-4. PubMed ID: 26037353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid prenatal diagnosis of aneuploidy for chromosomes 21, 18, 13, and X by quantitative fluorescence polymerase chain reaction.
    Ochshorn Y; Bar-Shira A; Jonish A; Yaron Y
    Fetal Diagn Ther; 2006; 21(4):326-31. PubMed ID: 16757905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
    Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
    Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.